James T. Borello
ALNY icon

James T. Borello’s Alnylam Pharmaceuticals ALNY Stock Holding History

James T. Borello’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.6K Sell
47
-7
-13% -$1.78K ﹤0.01% 563
2026
Q2 		$16.3K Buy
54
+23
+74% +$6.94K ﹤0.01% 466
2026
Q1 		$10.3K Buy
31
+10
+48% +$3.4K ﹤0.01% 559
2025
Q4 		$8.35K Buy
21
+6
+40% +$2.66K ﹤0.01% 463
2025
Q3 		$6.84K Buy
+15
New +$6.11K ﹤0.01% 372

Other funds holding ALNY

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

James T. Borello's ALNY Position: Q3 2026 in Review

James T. Borello reduced its Alnylam Pharmaceuticals (ALNY) stake by 13% in Q3 2026, selling an estimated $1.78K and leaving 47 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #563.

James T. Borello first reported a position in ALNY in Q3 2025 and has held it in 5 quarters since. The position peaked at $16.3K in Q2 2026. 206 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • James T. Borello held 47 shares of Alnylam Pharmaceuticals worth $11.6K as of Q3 2026.
  • James T. Borello sold 7 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $1.78K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of James T. Borello's portfolio in Q3 2026, its #563 holding.
  • James T. Borello first reported a position in Alnylam Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • James T. Borello's Alnylam Pharmaceuticals position peaked at $16.3K in Q2 2026.
  • 206 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on James T. Borello's 13F filing for Q3 2026, filed 16 Oct 2026.